NEWS

WIRES

OTHER

EpiCareSRT(TM) and Sensus Healthcare(TM) Form Strategic Partnership to Take Non-Melanoma Skin Cancer Treatment Mobile

BOCA RATON, Fla., Feb. 4, 2011 /PRNewswire/ -- EpiCareSRT(TM) (www.epicaresrt.com) announced today it has entered into a strategic partnership with Sensus Healthcare(TM) (www.sensushealthcare.com) to take new aim at skin cancer by providing the first mobile service to bring low-dose superficial radiation therapy directly to the point-of-care in dermatology offices.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO )

EpiCareSRT's mobile services application of the Sensus SRT-100(TM) system, utilizing proprietary mobile x-ray technology, advances patient care. It provides a new option for dermatologists to treat patients with basal cell and squamous cell carcinomas on an out-patient basis. When compared to other treatment modalities and surgical options, the SRT-100(TM) delivers high cure rates, low recurrence rates, no scarring and the convenience of treatment at the doctor's office.

"We are privileged to work with Sensus Healthcare in the fight against skin cancer," said Dale Ranney, CEO at EpiCareSRT. "We believe our solution improves the quality of care for the patient while increasing the value of the dermatologist's practice by bringing a very affordable, mobile non-surgical skin cancer treatment service to the point-of-care."

"We are very pleased to be working with EpiCareSRT. Bringing our technology to dermatology offices on a shared basis will give the dermatology community more treatment choices to offer their patients. Offering additional treatment options to patients will also allow Dermatologists to increase revenues and retain their patient base," said Steve Cohen, VP of Strategic Initiatives at Sensus Healthcare.

Superficial Radiation Therapy (SRT) is a clinically documented, well-established and reimbursable procedure. Sensus Healthcare's SRT-100(TM) system is optimal for mobile applications and meets stringent safety requirements set by the FDA, UL, ISO and CE Mark certification.

Visit both companies at the 69th Annual Meeting for the American Academy of Dermatology, February 4th-8th, 2011, New Orleans, LA in booth #3921.

About EpiCareSRT:

EpiCareSRT is the first provider of mobile non-surgical skin cancer treatment delivered to the point-of-care in the doctor's office. The company exclusively uses the Sensus Healthcare SRT-100(TM) system for cost-effective, non-invasive treatment of non-melanoma skin cancers. EpiCareSRT is headquartered in Saint Augustine, Florida with West Coast offices the San Francisco Bay Area. Visit the company online at www.epicaresrt.com.

About Sensus Healthcare:

Sensus Healthcare is taking new aim at non-melanoma skin cancer. We're focused on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, non-invasive treatment of non-melanoma skin cancers. The signature Sensus Healthcare product, the SRT-100(TM), meets stringent safety requirements set by the FDA, UL and ISO/CE Mark certification. Based in Boca Raton, FL, Sensus Healthcare employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations, and product reliability. Visit us online at www.sensushealthcare.com.

    Contact:
    Kathleen McCabe
    Marketing
    925.525.5538 | m
    kathleen.mccabe@epicaresrt.com

    Vicky Perez
    Public Relations
    561-922-5808 Ext 108
    vicky@sensushealthcare.com

SOURCE Sensus Healthcare